Cancer remains a high priority for the Government and despite survival rates being at a record high, too many people continue to die from it, leaving many devastated by the loss of loved ones. In the past decade, rates of survival from cancer have increased year-on-year. Around 7,000 people are alive today who would not have been had mortality rates stayed the same as then.

The NHS Long Term Plan (LTP), published during 2019, outlined a number of new measures for catching cancer early and providing treatment, with the aim that from 2028, 55,000 more people each year will survive their cancer for at least five years after diagnosis. One of the measures outlined in the plan is safer and more precise treatment, including advanced radiotherapy techniques and immunotherapies to continue to support improvements in survival rates. This will be supported by a £130 million upgrade of radiotherapy machines across England, including £32 million to replace 17 Linear Accelerators aged over 10 years by the end of March 2022, as well as commissioning the NHS new state-of-the-art Proton Beam facilities in London and Manchester.

In addition, the LTP commits to reforms to the specialised commissioning payments for radiotherapy hypofractionation to support further equipment upgrades. Faster, smarter and more effective radiotherapy, supported by greater networking of specialised expertise, will mean more patients are offered curative treatment, with fewer side effects and shorter treatment times. Starting with ovarian cancer, the NHS will ensure greater access to specialist expertise and knowledge in the treatment of cancers where there are fewer or more risky treatment options.

I hope that this provides reassurance that providing adequate support for a widely used and effective treatment for cancer is absolutely a priority for the Department of Health and Social Care and across the NHS.